Alitretinoin

This classification denotes a retinoic acid agent with the molecular formula C20H28O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 1UA8E65KDZ, chemically known as 2,4,6,8-nonatetraenoic acid, 3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-, (all-e)- but more generally known as alitretinoin, which bears US NIH Compound Identifier 444795. European Medicines Agency schedules Alitretinoin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00344MIG. The term ALITRETINOIN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 13 No. 3, 1999, List 42). World Health Organization schedules alitretinoin in its Anatomical Therapeutic Chemical (ATC) Classification. Most nations, for tariff and trade purposes, schedule alitretinoin under HS 29362100 and SITC 54112. As of Q4 2014, ALITRETINOIN remains US FDA's Preferred Term for this commodity. Alitretinoin bears US NLM identifiers UMLS ID C0281666 and NCI Concept Code C1574. SMILES: OC(=O)/C=C(/C=C/C=C(/C=C/C1=C(CCCC1(C)C)C)C)C.